Try our Advanced Search for more refined results

Actavis, Mylan Settle IP Suit Over Generic Birth Control Drug

By Zachary Zagger (April 15, 2014, 4:57 PM EDT) -- Actavis PLC has entered an agreement with generic drugmakers Mylan Laboratories Inc. and its partner Famy Care Ltd. to settle outstanding patent litigation over chewable tablets of the birth control drug Generess Fe, the companies said in separate statements Tuesday....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!